Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Current Trends in Nutrigenomics

영양유전체학(Nutrigenomics)의 최근 경향

  • Choi, Bong-Hyuk (School of Life and Food Sciences, Handong Global Univeristy) ;
  • Kim, Jong-Bae (School of Life and Food Sciences, Handong Global Univeristy) ;
  • Do, Myoung-Sool (School of Life and Food Sciences, Handong Global Univeristy)
  • 최봉혁 (한동대학교 생명식품과학부) ;
  • 김종배 (한동대학교 생명식품과학부) ;
  • 도명술 (한동대학교 생명식품과학부)
  • Published : 2005.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

With the decoding of human genome in 2004 and the recent development in nutritional science there has been an integration of molecular biology and nutrition. As a consequenc a now word ' molecular nutrition ' has been formed and recently the word 'nutrigenomics' is coined and widely being used. The field of science that showed the most positive result from grafting the science of nutrition and nutrigenomics is obesity. In 1994, Jeffrey Friedman from Rockeffeler University announced that ob gene and obesity has a close relationship and since then there's been a huge research done on genes related to obesity from the molecular nutrition's Point of view. Even now there are many genes presented which are supposed to be related to obesity and big efforts are put into finding what exactly those genes do. Moreover studying only in the context of genes was not enough so functional genomics, which is the study of the functions of cells and the functions and effects between genes and Protein Products, is being studied. This review article discusses the relationship between nutrition and genes and the general idea of nutrigenomics. The article also discusses about the current research status on these subjects.

Keywords

References

  1. Collins FS, Morgan M, Patrinos A. 2003. The human genome project: Lessons from large-scale biology. Science 300: 286-290 https://doi.org/10.1126/science.1084564
  2. Frazier ME, Johnson GM, Thomassen DG, Oliver CE, Patrinos A. 2003. Realizing the potential of the genome revolution: The genomes to life program. Science 300: 290-293 https://doi.org/10.1126/science.1084566
  3. Collins FS, Green ED, Guttmacher AE, Guyer MS. 2003. A vision for the future of genomics research. Nature 24: 835-847
  4. Carroll SB. 2003. Genetics and the making of Homo sapiens. Nature 24: 849-857
  5. Fransis GA, Fayard E, Picard F, Auwerx J. 2002. Nuclear receptors and the control of metabolism. Annu Rev Pltysiol 65: 261-311
  6. Trayhurn P. 2003. Nutritional genomics - 'Nutrigenomics', British Journal of Nutrition 89: 1-2
  7. Moon BC, Friedman JM. 1997. The molecular basis of the obese mutation in ob2J mice. Genomics 42: 152-156 https://doi.org/10.1006/geno.1997.4701
  8. Guengerich FP. 2001. Functional genomics and proteomics applied to the study of nutritional metabolism. Nutr Rev 59: 259-263 https://doi.org/10.1111/j.1753-4887.2001.tb05510.x
  9. Muller M, Kersten S. 2003. Nutrigenomics: goals and strategies. Nature Genetics 4: 315-322 https://doi.org/10.1038/nrg1047
  10. Trayhurn P. 1996. Northern blotting. Proceedings of the Nutrition Society 55: 583-589
  11. Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM. 1999. Expression profiling using cDNA microarrays. Nat Genet 21: 10-14 https://doi.org/10.1038/4434
  12. Hung SC, Chang CF, Ma HL, Chen TH, Low-Tone Ho L. 2004. Gene expression profiles of early adipogenesis in human mesenchymal stem cells. Gene 340: 141-150 https://doi.org/10.1016/j.gene.2004.06.028
  13. Pandey A, Mann M. 2000. Proteomics to study genes and genomes. Nature 405: 837-846 https://doi.org/10.1038/35015709
  14. Tyers M, Mann M. 2003. From genomics to proteomics. Nature 422: 193-197 https://doi.org/10.1038/nature01510
  15. Hannon GJ. 2002. RNA interference. Nature 418: 244-251 https://doi.org/10.1038/418244a
  16. Dykxhoorn DM, Novina CD, Sharp PA. 2003. Killing the messenger: short RNAs that silence gene expression. Nature Reviews Molecular Cell Biology 4: 457-467 https://doi.org/10.1038/nrm1129
  17. Raptis S, Dimitriadis G. 1985. Human insulin. Clin Physiol Biochem 3: 29-42
  18. Klemcke HG, Vallet JL, Christenson RK, Pearson PL. 2001. Erythropoietin mRNA expression in pig embryos. Anim Reprod Sci 66: 93-108 https://doi.org/10.1016/S0378-4320(01)00084-7
  19. Docherty K. 1996. Transgenic animals. Proceedings of the Nutrition Society 55: 613-618
  20. Fenech M, Ferguson LR. 2001. Vitamins/minerals and genomic stability in humans. Mutat Res 475: 1-6 https://doi.org/10.1016/S0027-5107(01)00069-0
  21. Chatterjee M. 2001. Vitamin D and genome stability. Mutat Res 475: 69-87 https://doi.org/10.1016/S0027-5107(01)00080-X
  22. Peehl DM, Feldman D. 2004. Interaction of nuclear receptor ligands with the vitamin D signaling pathway in prostate cancer. J Steroid Biochem Mol Biol 92: 307-315 https://doi.org/10.1016/j.jsbmb.2004.10.006
  23. Fenech M, Aitken C, Rinaldi J. 1998. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 19: 1163-1171 https://doi.org/10.1093/carcin/19.7.1163
  24. El-Bayoumy K. 2001. The protective role of selenium on genetic damage and on cancer. Mutat Res 475: 123-139 https://doi.org/10.1016/S0027-5107(01)00075-6
  25. Dreosti IE. 2001. Zinc and the gene. Mutat Res 475: 161-167 https://doi.org/10.1016/S0027-5107(01)00067-7
  26. Gadhavi PL, Raine AR, Alefounder PR, Laue ED. 1990. Complete assignment of the IH NMR spectrum and secondary structure of the DNA binding domain of GAL4. FEBS Lett 276: 49-53 https://doi.org/10.1016/0014-5793(90)80504-C
  27. Pan T, Coleman JE. 1991. Sequential assignments of the IH NMR resonances of Zn (II) 2 and 113Cd (II) 2 derivatives of the DNA-binding domain of the GAL4 transcription factor reveal a novel structural motif for specific DNA recognition. Biochemistry 30: 4212-4222 https://doi.org/10.1021/bi00231a016
  28. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P. 1997. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390: 311-315 https://doi.org/10.1038/36899
  29. Das A, Rajagopalan L, Mathura VS, Rigby SJ, Mitra S, Hazra TK. 2004. Identification of a zinc finger domain in the human NEIL2 (NeHike-2) protein. J Biol Chem 279: 47132-47138 https://doi.org/10.1074/jbc.M406224200
  30. Oshika E, Liu S, Singh G, Michalopoulos GK, Shinozuka H, Katyal SL. 1998. Antagonistic effects of dexamethasone and retinoic acid on rat lung morphogenesis. Paediatr Res 43: 315-324
  31. NiederreitherK, Subbarayan V, Dolle P, Chambon P. 1999. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nature Genet 21: 444-448 https://doi.org/10.1038/7788
  32. Underhill TM, Weston AD. 1998. Retinoids and their receptors in skeletal development. Microsc Res Tech 43: 137-155 https://doi.org/10.1002/(SICI)1097-0029(19981015)43:2<137::AID-JEMT7>3.0.CO;2-3
  33. Chambon P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J 10: 940-954 https://doi.org/10.1096/fasebj.10.9.8801176
  34. Egea PF, Rochel N, Birck C, Vachette P, Timmins PA, Moras D. 2001. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J Mol Biol 307: 557-576 https://doi.org/10.1006/jmbi.2000.4409
  35. Perlmann T, Rangarajan PN, Umesono K, Evans RM. 1993. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev 7: 1411-1422 https://doi.org/10.1101/gad.7.7b.1411
  36. Hong SE, Ahn IS, Jung HS, Rayner DV, Do MS. 2004. Effect of retinoic acid on leptin, glycerol, and glucose levels in mature rat adipocytes in vitro. J Med Food 7: 320-326 https://doi.org/10.1089/jmf.2004.7.320
  37. Kutuzova GD, DeLuca HF. 2004. Gene expression profiles in rat intestine identify pathways for 1, 25-dihydroxyvitamin D3 stimulated calcium absorption and clarify its immunomodulatory properties. Arch Biochem Biophys 432: 152-166 https://doi.org/10.1016/j.abb.2004.09.004
  38. Zmuda JM, Cauley JA, Ferrell RE. 2000. Molecular epidemiology of vitamin D receptor gene variants. Epidemiologic Reviews 22: 203-217 https://doi.org/10.1093/oxfordjournals.epirev.a018033
  39. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB. 1998. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139: 4391-4396 https://doi.org/10.1210/en.139.10.4391
  40. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB. 1999. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology 140: 4982-4987 https://doi.org/10.1210/en.140.11.4982
  41. Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R, Carmeliet G. 2001. Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects. Proc Natl Amd Sci USA 98: 13324-13329
  42. Sugiyama T, Kawai S. 2001. Carboxylation of osteocalcin may be related to bone quality: a possible mechanism of bone fracture prevention by vitamin K. J Bone Miner Metab 19: 146-149 https://doi.org/10.1007/s007740170034
  43. Uitterlinden AG, Fang Y, Bergink AP, van Meurs JB, van Leeuwen HP, Pols HA. 2002. The role of vitamin D receptor gene polyrnorphisms in bone biology. Molecular and Cellular Endocrinology 197: 15-21 https://doi.org/10.1016/S0303-7207(02)00274-5
  44. Jump DB. 2002 The biochemistry of n-S polyunsaturated fatty acids. Journal of Biological Chemistry 277: 8755-8758 https://doi.org/10.1074/jbc.R100062200
  45. Goodridge AG. 1987. Dietary regulation of gene expression: enzymes involved in carbohydrate and lipid metabolism. Annual Reviews of Nutrition 7: 157-185 https://doi.org/10.1146/annurev.nu.07.070187.001105
  46. Yamada K, Noguchi T. 1999. Nutrient and hormonal regulation of pyruvate kinase gene expression. Biochem J 337: 1-11 https://doi.org/10.1042/0264-6021:3370001
  47. Gosiewska A, Mahmoodian F, Peterkofsky B. 1996. Gene expression of iron-related proteins during iron deficiency caused by scurvy in guinea pigs. Arch Biochem Biophys 325: 295-303 https://doi.org/10.1006/abbi.1996.0037
  48. Ponka P. 1999. Cellular iron metabolism. Kidney Int Suppl 69: 2-11
  49. Cairo G, Recalcati S, Pietrangelo A, Minotti G. 2002. The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Radic Biol Med 32: 1237-1243 https://doi.org/10.1016/S0891-5849(02)00825-0
  50. Kramer G, Henderson AB, Pinphanichakarn P, Wallis MH, Hardesty B. 1977. Partial reaction of peptide initiation inhibited by phosphorylation of either initiation factor eIF-2 or 40S ribosomal proteins. Proc Natl Acad Sci USA 74: 1445-1449
  51. Rutter GA, Leclerc I, Tsuboi T, Xavier Gda S, Diraison F, Qian Q. 2004. Imaging glucose-regulated insulin secretion and gene expression in single islet beta-cells: Control by AMP-activated protein kinase. Cell Biochem Biophys 40: 179-190 https://doi.org/10.1385/CBB:40:3S:179
  52. Kwok PY, Gu Z. 1999. Single nucleotide polymorphism libraries: why and how are we building them? Molecular medicine Today 5: 538-543 https://doi.org/10.1016/S1357-4310(99)01601-9
  53. Nakamura Y. 1999. Impact of human genome analysis on the future medicine. Nippon Yakurigaku Zasshi 114: 126-130 https://doi.org/10.1254/fpj.114.126
  54. Tataranni PA, Ravussin E. 1997. Effect of fat intake on energy balance. Ann N Y Acad Sci 819: 37-43 https://doi.org/10.1111/j.1749-6632.1997.tb51797.x
  55. Garaulet M, Marin C, Perez-Llamas F, Canterasl M, Tebar FJ, Zamora S. 2004. Adiposity and dietary intake in cardiovascular risk in an obese population from a Mediterranean area. J Physiol Biochem 60: 39-49 https://doi.org/10.1007/BF03168219
  56. Singhal A, Fewtrell M, Cole TJ, Lucas A. 2003. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet 361: 1089-1097 https://doi.org/10.1016/S0140-6736(03)12895-4
  57. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Finnell RH, Zhu H, Andreussi L, Cama A, Capra V. 2002. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47: 319-324 https://doi.org/10.1007/s100380200043
  58. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al. 1995. A candidate genetic risk factor forvascular disease: a common mutation in methylenete-trahydrofolate reductase. Nat Genet 10: 111-113 https://doi.org/10.1038/ng0595-111
  59. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, Mariman EC, den Heyer M, Rozen H, Blom HJ, 1995. Mutated methylenetetrahydrofolate reductase as risk factor for spina bifida, Lancet 346: 1070-1071 https://doi.org/10.1016/S0140-6736(95)91743-8
  60. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. 2001. Biological and clinical implications of the MTHFR C677T polymorphism. Trends in Pharmacological Sciences 22: 195-201 https://doi.org/10.1016/S0165-6147(00)01675-8
  61. Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM. 2004. MTHFR C677T and A1298C polyrnorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 13: 285-292 https://doi.org/10.1158/1055-9965.EPI-03-0083
  62. Malloy PJ, Zhu W, Bouillon R, Feldman D. 2002. A novel nonsense mutation in the ligand binding domain of the vitamin D receptor causes hereditary 1, 25-dihydroxyvitamin D-resistant rickets. Mol Genet Metab 77: 314-318 https://doi.org/10.1016/S1096-7192(02)00173-7
  63. Nejentsev S, Cooper JD, Godfrey L, Howson JM, Rance H, Nutland S, Walker NM, Guja C, Ionescu-Tirgoviste C, Savage DA, Undlien DE, Ronningen KS, Tuomilehto-Wolf E, Tuomilehto J, Gillespie KM, Ring SM, Strachan DP, Widmer B, Dunger D, Todd JA. 2004. Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes 53: 2709-2712 https://doi.org/10.2337/diabetes.53.10.2709
  64. Shiina T, Inoko H, Kulski JK. 2004. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64: 631-649 https://doi.org/10.1111/j.1399-0039.2004.00327.x
  65. Leffell MS. 2002. MHC polymorphism: Coping with the allele explosion. Clinical and Applied Immunology Reviews 3: 35-46 https://doi.org/10.1016/S1529-1049(02)00062-4
  66. Guandalini S, Gupta P. 2002. Celiac disease: A diagnostic challenge with many facets. Clinical and Applied Immunology Reviews 2: 293-305 https://doi.org/10.1016/S1529-1049(02)00052-1
  67. Bojkovic G, Caparevic Z, Ilic V, Stojanovic D, Lalosevic D, Stojanovic M. 2002. Case report: celiac disease. Med Pregl 55: 532-534 https://doi.org/10.2298/MPNS0212532B
  68. Morali A. 2002. Celiac disease: clinical and subclinical forms. Allerg Immunol (Paris) 34: 100-102
  69. Stazi A V, Mantovani A. 2000. A risk factor for female fertility and pregnancy: celiac disease. Gynecol Endocrinol 14: 454-463 https://doi.org/10.3109/09513590009167719
  70. Lomer MC, Kodjabashia K, Hutchinson C, Greenfield SM, Thompson RP, Powell JJ. 2004. Intake of dietary iron is low in patients with Crohns disease: a case-control study. Br J Nutr 91: 141-148 https://doi.org/10.1079/BJN20041022
  71. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. 1999. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20: 68-100 https://doi.org/10.1210/er.20.1.68
  72. Kopecky J, Flachs P, Bardova K, Brauner P, Prazak T, Sponarova J. 2002. Modulation of lipid metabolism by energy status of adipocytes: implications for insulin sensitivity. Ann N Y Acad Sci 967: 88-101 https://doi.org/10.1111/j.1749-6632.2002.tb04267.x
  73. Fontaine C, Dubois G, Duguay Y, Helledie T, Vu-Dac N, Gervois P, Soncin F, Mandrup S, Fruchart JC, Fruchart-Najib J. Staels B. 2003. The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferatot-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation. J Biol Chem 278: 37672-37680 https://doi.org/10.1074/jbc.M304664200
  74. Tamori Y, Masugi J. Nishino N, Kasuga M. 2002. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51: 2045-2055 https://doi.org/10.2337/diabetes.51.7.2045
  75. Cowherd RM, Lyle RE, McGehee RE Jr. 1999. Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol 10: 3-10 https://doi.org/10.1006/scdb.1998.0276
  76. Prusty D, Park BH, Davis KE, Farmer SR. 2002. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3- L1 preadipocytes. J Biol Chem 277: 46226-46232 https://doi.org/10.1074/jbc.M207776200
  77. 조혜진, 김우식, 박소윤, 김재범. 2002. 체내 에너지 대사 조절의 중추적 기능을 담당하는 PPAR과 UCP. Biochemistry News 22: 256-265
  78. Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, Attie AD. 2000. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci USA 97: 11371-11376
  79. Soukas A, Cohen P, Socci ND, Friedman JM. 2000. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev 14: 963-980
  80. Lopez IP, Marti A, Milagro Fl, Zulet Md Mde L, Moreno-Aliaga MJ, Martinez JA, De Miguel C. 2003. DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. Obes Res 11: 188-194 https://doi.org/10.1038/oby.2003.30
  81. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. 2003. PGCIalpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273 https://doi.org/10.1038/ng1180
  82. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Bema R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ. 2003. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGCl and NRF1. Proc Natl Acad Sci USA 100: 8466-8471
  83. Cowherd RM, Lyle RE,McGehee RE Jr. 1999. Molecular regulation of adipocyte differentiation. Semin Cell Deu Biol 10: 3-10 https://doi.org/10.1006/scdb.1998.0276
  84. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, Ahringer J. Ruvkun G. 2003. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421: 268-272 https://doi.org/10.1038/nature01279
  85. Brockmann GA, Bevova MR. 2002. Using mouse models to dissect the genetics of obesity. Trends Genet 18: 367-376 https://doi.org/10.1016/S0168-9525(02)02703-8
  86. Borchardt JK. 2004. Medicinal chemistry: new technologies and developments. Drug Discov Today 9: 737-739 https://doi.org/10.1016/S1359-6446(04)03140-X
  87. Challis BG, Yeo GS. 2002. Past, present and future strategies to study the genetics of body weight regulation. Brief Funct Genomic Proteomic 1: 290-304 https://doi.org/10.1093/bfgp/1.3.290
  88. Halvorsen YD, Wilkison WO, Briggs MR. 2000. Human adipocyte proteomics - a complementary way of looking at fat. Pharmacogenomics 1: 179-185 https://doi.org/10.1517/14622416.1.2.179
  89. Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Uu SM, Tartaglia L, Leibel RL. 1996. Phenotypes of mouse diabetes and rat fatty due to mutations in the ob (leptin) receptor, Science 271: 994-996 https://doi.org/10.1126/science.271.5251.994
  90. Docherty K. 1996. Transgenic animals. Proceedings of the Nutrition Society 55: 613-618
  91. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, GuyGrand B. 1998. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392: 398-401 https://doi.org/10.1038/32911
  92. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homolog. Nature 372: 425-432 https://doi.org/10.1038/372425a0
  93. Trayhurn P.1996. New insights into the development of obesity - obese genes and the leptin system. Proceedings of the Nutrition Society 55: 783-791
  94. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. 1998. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 18: 213-215 https://doi.org/10.1038/ng0398-213
  95. Boyce RS, Duhl DM. 2004. Melanocortin-4 receptor agonists for the treatment of obesity. Curr Opin Investig Drugs 5: 1063-1071
  96. Yiannakouris N, Melistas L, Kontogianni M, Heist K, Mantzoros CS. 2004. The Val81 missense mutation of the melanocortin 3 receptor gene, but not the 1908c/T nucleotide polymorphism in lamin NC gene, is associated with hyperleptinemia and hyperinsulinemia in obese Greek caucasians. J Endocrinol Invest 27: 714-720 https://doi.org/10.1007/BF03347511
  97. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T, Biebermann H, Wichmann HE, Schafer H, Hinney A, Hebebrand J 2004. Melanocortin-4 receptor gene variant 1103 is negatively associated with obesity. Am J Hum Genet 74: 572-581 https://doi.org/10.1086/382490
  98. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. 1997. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387: 903-908 https://doi.org/10.1038/43185
  99. Martinez JA, Corbalan MS, Sanchez-Villegas A, Forga L, Marti A, Martinez-Gonzalez MA. 2003. Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu $\beta$2-adrenoceptor polymorphism. J Nutr 133: 2549-2554
  100. Trayhurn P, Duncan JS, Wood AM, Beattie JH. 2000. Metallothionein gene expression and secretion in white adipose tissue. Am J Physiol Regul Integr Comp Physiol 279: 2329-2335 https://doi.org/10.1152/ajpregu.2000.279.6.R2329
  101. Adams SH. 2000. Uncoupling protein homologs: emerging views of physiological function. J Nutr 130: 711-714
  102. De Matteis R, Arch JR, Petroni ML, Ferrari D, Cinti S, Stock MJ 2002. Immunohistochemical identification of the ${\beta}_3$-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int J Obes Relat Metab Disord 26: 1442-1450 https://doi.org/10.1038/sj.ijo.0802148

Cited by

  1. Personalized Dietary SikdanOme Recommendation based on Obesity Related SNP Genotype and Phenotype vol.16, pp.10, 2016, https://doi.org/10.5392/JKCA.2016.16.10.435
  2. 젓갈로부터 분리된 글루텐 분해능을 가지는 Weissella confusa 균주와 특성 vol.23, pp.6, 2005, https://doi.org/10.11002/kjfp.2016.23.6.883
  3. Effects of Sodium Intake on the Association between the Salt-Sensitive Gene, Alpha-Adducin 1 (ADD1), and Inflammatory Cytokines in the Prevalence of Children Obesity vol.7, pp.2, 2005, https://doi.org/10.12997/jla.2018.7.2.98